Training for Men Undergoing Androgen Deprivation Therapy.
About this study
The goal of this clinical trial is to evaluate the effects of a newly developed training concept on men with prostate cancer undergoing androgen deprivation therapy (ADT). The main questions it aims to answer are: * How feasible and safe is the new training concept? * How efficient is the training concept to counteract side effects caused by ADT? Researchers will compare the new training concept with usual care to evaluate how efficient the training concept is to counteract the ADT-related side effects. Participants in the intervention group will perform the new training concept twice weekly for 12 weeks. Participants in the control group will only receive usual care. All participants will visit the laboratory at baseline and after 6 and 12 weeks to measure the primary and secondary outcomes.
- Condition
- Prostate Cancer
- Tested
- ADT-train
- Sponsor
- The Swedish School of Sport and Health Sciences
Who can join
- Age
- 50 to 80 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
Inclusion 7
- Minimum age: 50 years
- Maximum age: 80 years
- Eligible sex: Male
- Study condition: Prostate Cancer
- signed informed consent
- histologically confirmed localised or locally advanced prostate cancer
- planned radiotherapy in combination with ADT for at least six months (unfavorable intermediate risk and high-risk prostate cancer) with curative intent and with no known metastasis.
Exclusion 5
- very high risk localised prostate cancer planned for radiotherapy and ADT plus abiraterone and cortisone
- localized prostate cancer planned for radiotherapy without ADT
- on-going or previously treated with ADT or other hormonal treatments
- have any contraindications to physical testing/exercise as per the ACSM guidelines
- unable to comply with study procedures
Where
1 site, 1 recruiting
Swedish School of Sport and Health Sciences
Stockholm, Sweden
Contact
-
Niklas Psilander, PhD
+46 8 120 538 23 niklas.psilander@gih.se
Potential match only. Final eligibility is determined by the study team.